Selected research
Market Analysis & Forecast
Global Healthcare Apps for Patients Market Analysis and Forecast 2026-2032
Market perspective
The global Healthcare Apps for Patients market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Healthcare Apps for Patients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Healthcare Apps for Patients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Healthcare Apps for Patients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Healthcare Apps for Patients is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Healthcare Apps for Patients include Medisafe, Medical ID, Dminder, MyFitnessPal, Diabetes:M, Heal, Eyecare Live, AliveCor and mySymptoms, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Healthcare Apps for Patients, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Healthcare Apps for Patients, also provides the revenue of main regions and countries. Of the upcoming market potential for Healthcare Apps for Patients, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Healthcare Apps for Patients revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Healthcare Apps for Patients market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Healthcare Apps for Patients revenue, projected growth trends, production technology, application and end-user industry.
Healthcare Apps for Patients Segment by Company
Medisafe
Medical ID
Dminder
MyFitnessPal
Diabetes:M
Heal
Eyecare Live
AliveCor
mySymptoms
Teladoc
Epocrates
Eyecarelive
MyChart
Doximity
Amwell
UpToDate
Healthcare Apps for Patients Segment by Type
iOS
Android
Healthcare Apps for Patients Segment by Application
Patients
Relatives of Patient
Healthcare Apps for Patients Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Healthcare Apps for Patients market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Healthcare Apps for Patients and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Healthcare Apps for Patients.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Healthcare Apps for Patients in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Healthcare Apps for Patients company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Healthcare Apps for Patients revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- iOS
- Android
Applications
- Patients
- Relatives of Patient
Companies covered
- Medisafe
- Medical ID
- Dminder
- MyFitnessPal
- Diabetes:M
- Heal
- Eyecare Live
- AliveCor
- mySymptoms
- Teladoc
- Epocrates
- Eyecarelive
- MyChart
- Doximity
- Amwell
- UpToDate
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Healthcare Apps for Patients Market by Type
- 1.2.1 Global Healthcare Apps for Patients Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 iOS
- 1.2.3 Android
- 1.3 Healthcare Apps for Patients Market by Application
- 1.3.1 Global Healthcare Apps for Patients Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Patients
- 1.3.3 Relatives of Patient
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Healthcare Apps for Patients Market Dynamics
- 2.1 Healthcare Apps for Patients Industry Trends
- 2.2 Healthcare Apps for Patients Industry Drivers
- 2.3 Healthcare Apps for Patients Industry Opportunities and Challenges
- 2.4 Healthcare Apps for Patients Industry Restraints
3 Global Growth Perspective
- 3.1 Global Healthcare Apps for Patients Market Perspective (2021-2032)
- 3.2 Global Healthcare Apps for Patients Growth Trends by Region
- 3.2.1 Global Healthcare Apps for Patients Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Healthcare Apps for Patients Market Size by Region (2021-2026)
- 3.2.3 Global Healthcare Apps for Patients Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Healthcare Apps for Patients Revenue by Players
- 4.1.1 Global Healthcare Apps for Patients Revenue by Players (2021-2026)
- 4.1.2 Global Healthcare Apps for Patients Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Healthcare Apps for Patients Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Healthcare Apps for Patients Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Healthcare Apps for Patients Key Players Headquarters & Area Served
- 4.4 Global Healthcare Apps for Patients Players, Product Type & Application
- 4.5 Global Healthcare Apps for Patients Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Healthcare Apps for Patients Market CR5 and HHI
- 4.6.3 2025 Healthcare Apps for Patients Tier 1, Tier 2, and Tier 3
5 Healthcare Apps for Patients Market Size by Type
- 5.1 Global Healthcare Apps for Patients Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Healthcare Apps for Patients Revenue by Type (2021-2032)
- 5.3 Global Healthcare Apps for Patients Revenue Market Share by Type (2021-2032)
6 Healthcare Apps for Patients Market Size by Application
- 6.1 Global Healthcare Apps for Patients Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Healthcare Apps for Patients Revenue by Application (2021-2032)
- 6.3 Global Healthcare Apps for Patients Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 Medisafe
- 7.1.1 Medisafe Company Information
- 7.1.2 Medisafe Business Overview
- 7.1.3 Medisafe Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.1.4 Medisafe Healthcare Apps for Patients Product Portfolio
- 7.1.5 Medisafe Recent Developments
- 7.2 Medical ID
- 7.2.1 Medical ID Company Information
- 7.2.2 Medical ID Business Overview
- 7.2.3 Medical ID Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.2.4 Medical ID Healthcare Apps for Patients Product Portfolio
- 7.2.5 Medical ID Recent Developments
- 7.3 Dminder
- 7.3.1 Dminder Company Information
- 7.3.2 Dminder Business Overview
- 7.3.3 Dminder Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.3.4 Dminder Healthcare Apps for Patients Product Portfolio
- 7.3.5 Dminder Recent Developments
- 7.4 MyFitnessPal
- 7.4.1 MyFitnessPal Company Information
- 7.4.2 MyFitnessPal Business Overview
- 7.4.3 MyFitnessPal Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.4.4 MyFitnessPal Healthcare Apps for Patients Product Portfolio
- 7.4.5 MyFitnessPal Recent Developments
- 7.5 Diabetes:M
- 7.5.1 Diabetes:M Company Information
- 7.5.2 Diabetes:M Business Overview
- 7.5.3 Diabetes:M Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.5.4 Diabetes:M Healthcare Apps for Patients Product Portfolio
- 7.5.5 Diabetes:M Recent Developments
- 7.6 Heal
- 7.6.1 Heal Company Information
- 7.6.2 Heal Business Overview
- 7.6.3 Heal Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.6.4 Heal Healthcare Apps for Patients Product Portfolio
- 7.6.5 Heal Recent Developments
- 7.7 Eyecare Live
- 7.7.1 Eyecare Live Company Information
- 7.7.2 Eyecare Live Business Overview
- 7.7.3 Eyecare Live Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.7.4 Eyecare Live Healthcare Apps for Patients Product Portfolio
- 7.7.5 Eyecare Live Recent Developments
- 7.8 AliveCor
- 7.8.1 AliveCor Company Information
- 7.8.2 AliveCor Business Overview
- 7.8.3 AliveCor Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.8.4 AliveCor Healthcare Apps for Patients Product Portfolio
- 7.8.5 AliveCor Recent Developments
- 7.9 mySymptoms
- 7.9.1 mySymptoms Company Information
- 7.9.2 mySymptoms Business Overview
- 7.9.3 mySymptoms Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.9.4 mySymptoms Healthcare Apps for Patients Product Portfolio
- 7.9.5 mySymptoms Recent Developments
- 7.10 Teladoc
- 7.10.1 Teladoc Company Information
- 7.10.2 Teladoc Business Overview
- 7.10.3 Teladoc Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.10.4 Teladoc Healthcare Apps for Patients Product Portfolio
- 7.10.5 Teladoc Recent Developments
- 7.11 Epocrates
- 7.11.1 Epocrates Company Information
- 7.11.2 Epocrates Business Overview
- 7.11.3 Epocrates Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.11.4 Epocrates Healthcare Apps for Patients Product Portfolio
- 7.11.5 Epocrates Recent Developments
- 7.12 Eyecarelive
- 7.12.1 Eyecarelive Company Information
- 7.12.2 Eyecarelive Business Overview
- 7.12.3 Eyecarelive Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.12.4 Eyecarelive Healthcare Apps for Patients Product Portfolio
- 7.12.5 Eyecarelive Recent Developments
- 7.13 MyChart
- 7.13.1 MyChart Company Information
- 7.13.2 MyChart Business Overview
- 7.13.3 MyChart Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.13.4 MyChart Healthcare Apps for Patients Product Portfolio
- 7.13.5 MyChart Recent Developments
- 7.14 Doximity
- 7.14.1 Doximity Company Information
- 7.14.2 Doximity Business Overview
- 7.14.3 Doximity Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.14.4 Doximity Healthcare Apps for Patients Product Portfolio
- 7.14.5 Doximity Recent Developments
- 7.15 Amwell
- 7.15.1 Amwell Company Information
- 7.15.2 Amwell Business Overview
- 7.15.3 Amwell Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.15.4 Amwell Healthcare Apps for Patients Product Portfolio
- 7.15.5 Amwell Recent Developments
- 7.16 UpToDate
- 7.16.1 UpToDate Company Information
- 7.16.2 UpToDate Business Overview
- 7.16.3 UpToDate Healthcare Apps for Patients Revenue and Gross Margin (2021-2026)
- 7.16.4 UpToDate Healthcare Apps for Patients Product Portfolio
- 7.16.5 UpToDate Recent Developments
8 North America
- 8.1 North America Healthcare Apps for Patients Revenue (2021-2032)
- 8.2 North America Healthcare Apps for Patients Revenue by Type (2021-2032)
- 8.2.1 North America Healthcare Apps for Patients Revenue by Type (2021-2026)
- 8.2.2 North America Healthcare Apps for Patients Revenue by Type (2027-2032)
- 8.3 North America Healthcare Apps for Patients Revenue Share by Type (2021-2032)
- 8.4 North America Healthcare Apps for Patients Revenue by Application (2021-2032)
- 8.4.1 North America Healthcare Apps for Patients Revenue by Application (2021-2026)
- 8.4.2 North America Healthcare Apps for Patients Revenue by Application (2027-2032)
- 8.5 North America Healthcare Apps for Patients Revenue Share by Application (2021-2032)
- 8.6 North America Healthcare Apps for Patients Revenue by Country
- 8.6.1 North America Healthcare Apps for Patients Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Healthcare Apps for Patients Revenue by Country (2021-2026)
- 8.6.3 North America Healthcare Apps for Patients Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Healthcare Apps for Patients Revenue (2021-2032)
- 9.2 Europe Healthcare Apps for Patients Revenue by Type (2021-2032)
- 9.2.1 Europe Healthcare Apps for Patients Revenue by Type (2021-2026)
- 9.2.2 Europe Healthcare Apps for Patients Revenue by Type (2027-2032)
- 9.3 Europe Healthcare Apps for Patients Revenue Share by Type (2021-2032)
- 9.4 Europe Healthcare Apps for Patients Revenue by Application (2021-2032)
- 9.4.1 Europe Healthcare Apps for Patients Revenue by Application (2021-2026)
- 9.4.2 Europe Healthcare Apps for Patients Revenue by Application (2027-2032)
- 9.5 Europe Healthcare Apps for Patients Revenue Share by Application (2021-2032)
- 9.6 Europe Healthcare Apps for Patients Revenue by Country
- 9.6.1 Europe Healthcare Apps for Patients Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Healthcare Apps for Patients Revenue by Country (2021-2026)
- 9.6.3 Europe Healthcare Apps for Patients Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Healthcare Apps for Patients Revenue (2021-2032)
- 10.2 China Healthcare Apps for Patients Revenue by Type (2021-2032)
- 10.2.1 China Healthcare Apps for Patients Revenue by Type (2021-2026)
- 10.2.2 China Healthcare Apps for Patients Revenue by Type (2027-2032)
- 10.3 China Healthcare Apps for Patients Revenue Share by Type (2021-2032)
- 10.4 China Healthcare Apps for Patients Revenue by Application (2021-2032)
- 10.4.1 China Healthcare Apps for Patients Revenue by Application (2021-2026)
- 10.4.2 China Healthcare Apps for Patients Revenue by Application (2027-2032)
- 10.5 China Healthcare Apps for Patients Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Healthcare Apps for Patients Revenue (2021-2032)
- 11.2 Asia Healthcare Apps for Patients Revenue by Type (2021-2032)
- 11.2.1 Asia Healthcare Apps for Patients Revenue by Type (2021-2026)
- 11.2.2 Asia Healthcare Apps for Patients Revenue by Type (2027-2032)
- 11.3 Asia Healthcare Apps for Patients Revenue Share by Type (2021-2032)
- 11.4 Asia Healthcare Apps for Patients Revenue by Application (2021-2032)
- 11.4.1 Asia Healthcare Apps for Patients Revenue by Application (2021-2026)
- 11.4.2 Asia Healthcare Apps for Patients Revenue by Application (2027-2032)
- 11.5 Asia Healthcare Apps for Patients Revenue Share by Application (2021-2032)
- 11.6 Asia Healthcare Apps for Patients Revenue by Country
- 11.6.1 Asia Healthcare Apps for Patients Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Healthcare Apps for Patients Revenue by Country (2021-2026)
- 11.6.3 Asia Healthcare Apps for Patients Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Healthcare Apps for Patients Revenue (2021-2032)
- 12.2 SAMEA Healthcare Apps for Patients Revenue by Type (2021-2032)
- 12.2.1 SAMEA Healthcare Apps for Patients Revenue by Type (2021-2026)
- 12.2.2 SAMEA Healthcare Apps for Patients Revenue by Type (2027-2032)
- 12.3 SAMEA Healthcare Apps for Patients Revenue Share by Type (2021-2032)
- 12.4 SAMEA Healthcare Apps for Patients Revenue by Application (2021-2032)
- 12.4.1 SAMEA Healthcare Apps for Patients Revenue by Application (2021-2026)
- 12.4.2 SAMEA Healthcare Apps for Patients Revenue by Application (2027-2032)
- 12.5 SAMEA Healthcare Apps for Patients Revenue Share by Application (2021-2032)
- 12.6 SAMEA Healthcare Apps for Patients Revenue by Country
- 12.6.1 SAMEA Healthcare Apps for Patients Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Healthcare Apps for Patients Revenue by Country (2021-2026)
- 12.6.3 SAMEA Healthcare Apps for Patients Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst